BCR-ABL transkript levels and BCR-ABL/ABL transcript ratios in CML patients with good or bad response to treatment.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F01%3A00002004" target="_blank" >RIV/00023736:_____/01:00002004 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
BCR-ABL transkript levels and BCR-ABL/ABL transcript ratios in CML patients with good or bad response to treatment.
Original language description
Study of BCR-ABL transcript levels and BCR-ABL/BCR transcript ratios in CML patients treated either with interferon or with conventional chemotherapy in order to examine the proportion of BCR-ABL and BCR gene expression in different responses to treatmen, , ,
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NC5902" target="_blank" >NC5902: Molecular markers of chronic myeloid leukemia progression to blast crisis.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Blood
ISSN
—
e-ISSN
—
Volume of the periodical
98
Issue of the periodical within the volume
11B
Country of publishing house
US - UNITED STATES
Number of pages
1
Pages from-to
264
UT code for WoS article
—
EID of the result in the Scopus database
—